7 Immune Disorders and Disorders of Uncertain Etiology Hypersensitivity reaction to Aspergillus spores with mucoid impaction. Epidemiology Most common bronchopulmonary mycosis in humans Affects younger adults (ages 20–40; women slightly more often than men) Atopic patients with bronchial asthma or in the setting of cystic fibrosis (occurs in 10% of cystic fibrosis patients, 1–2% of asthma patients). Etiology, pathophysiology, pathogenesis Type I or III hypersensitivity reaction in the bronchial system and the adjacent lung tissue Leads to cystic-varicose bronchiectasis. Modality of choice CT is preferable to plain radiography. Radiographic and CT findings Linear shadow bands bifurcate to form V- or Y–shaped figures (bronchoceles, i.e., cystic mucus-filled bronchiectatic areas); there may be fluid shadows Mucus obstruction causes atelectasis Transient eosinophilic infiltrates Predilection for the proximal bronchial areas, and the upper and middle lung fields. Pathognomonic findings Bifurcating linear shadow bands “Finger in glove” and “toothpaste” shadows. Typical presentation Chronic recurrent asthma Cough with viscous sputum Hemoptysis Eosinophilia Hyphae in the sputum Antigen reaction. Therapeutic options Steroids. Course and prognosis Variable Recurrent allergic bronchopulmonary aspergillosis leads to central bronchiectasis and fibrosis in the upper field. What does the clinician want to know? Suspected diagnosis.
Allergic Bronchopulmonary Aspergillosis
Definition
Imaging Signs
Clinical Aspects
Differential Diagnosis
Cystic fibrosis and/or bronchiectasis | – No blood eosinophilia – Generalized changes and known underlying disorder in cystic fibrosis |
Bronchial atresia | – Usually in the apical posterior left upper lobe – Increased transradiancy and diminished vascularity – No history of allergy or cystic fibrosis |
Bronchocentric granulomatosis | – Solitary or multiple sublobular consolidations in close proximity to the airways, usually unilaterally in the upper fields – Where asthma is present, findings are indistinguishable from allergic bronchopulmonary aspergillosis |
Tips and Pitfalls
Findings are nonspecific.
Selected References
Franquet T et al. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 2001; 21: 825–837
Johkoh T et al. Eosinophilic lung diseases: diagnostic accuracy of thin section CT in 111 patients. Radiology 2000; 216: 773–780
Ward S et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999; 173: 937–942
Extrinsic Allergic Alveolitis or Hypersensitivity Pneumonitis
Definition
Immune reaction of the alveoli and bronchioles to inhalation of toxic substances Synonym: Organic dust toxic syndrome.
Epidemiology
Typical constellations are named after the specific type of exposure Farmer’s lung (thermophilic actinomycetes) Pigeon breeder’s lung (proteins) Ventilator pneumonitis or Monday morning fever (heat tolerant bacteria), etc.
Etiology, pathophysiology, pathogenesis
Allergic granulomatous reaction (bronchiolitis and alveolitis) Inhalation of animal proteins, pathogenic microorganisms, spores, mineral oils, chemical organic substances (measuring 1–5 µm) Prerequisite is an individual predisposition In the acute stage there is bronchiolitis with proliferation of alveolar cells Subacute stage involves development of interstitial granulomas The chronic stage includes development of interstitial fibrosis, honeycomb lung, and cysts.
Imaging Signs
Modality of choice
CT.
Radiographic findings
Findings are usually normal in the acute and subacute stages Rarely, there will be discrete ground-glass opacities or nodular and reticulonodular changes The chronic stage includes fibrosis predominantly in the middle field that spares the costophrenic angle.
CT findings
– Acute and subacute stages: Disseminated, ill-defined centrilobular nodules that can resemble ground-glass lesions Diffuse or nodular ground-glass opacity Predominantly in the middle and lower lung fields.
– Chronic stage: Honeycomb fibrosis, cystic changes, traction bronchiectasis, and volume loss No pleural or subpleural involvement No lymphadenopathy.
Pathognomonic findings
In the subacute phase these include diffuse and nodular ground-glass opacities, ill-defined centrilobular nodules (acinar nodules), predominantly in the middle and lower lung fields Later findings include fibrotic changes, acinar nodules, and ground-glass opacities.
Clinical Aspects
Typical presentation
The acute stage (4–8 hours after exposure) is characterized by flulike symptoms, nonproductive cough with dyspnea, resolving within 1–2 weeks The subacute chronic stage manifests as recurrent, episodic, and progressive shortness of breath (a sign of restrictive and obstructive pulmonary dysfunction).
History (antigen exposure and time-dependent symptoms), specifically immunoglobulin G (IgG) antibodies, radiographic findings, decreased pO2 Diagnosis is confirmed by bronchoalveolar lavage and by bronchial provocation testing where indicated.
Therapeutic options
Prophylaxis against exposure Steroids.
Course and prognosis
Variable Prognosis is good with prompt diagnosis and prophylaxis against exposure.
What does the clinician want to know?
Extent of organ manifestation Disease activity Course under therapy.
Differential Diagnosis
Toxic alveolitis | – Normal radiographic findings – No pulmonary dysfunction or impaired diffusion – No antibodies |
Bronchopulmonary infection | – History – Course under antibiotics – Bronchoalveolar lavage |
Nonspecific interstitial pneumonitis | – Ground-glass opacities – Peribronchovascular distribution – No honeycombing – Histologic examination recommended to exclude extrinsic allergic alveolitis |
Respiratory bronchiolitis with interstitial lung disease | – Smoker – Centrilobular emphysema – Primarily in the upper lobes |
Silicosis | – History of occupational exposure |
Sarcoidosis | – Peribronchovascular distribution – Lymphadenopathy |
Scleroderma | – Predominantly basal fibrosis – Esophageal dilatation |
Tips and Pitfalls
The acute stage is often misdiagnosed as a flulike infection The chronic stage is indistinguishable from other chronic inflammatory pulmonary disorders.
Selected References
Lynch DA et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995; 165: 807–811
Matar LD, McAdams HP, Sporn TA. Hypersensitivity pneumonitis. AJR Am J Roentgenol 2000; 174: 1061–1066
Sennekamp J, Müller-Wening D. [Exogen-allergische Alveolitis.] Pneumologe 2006; 3: 461–470 [In German]
Eosinophilic Lung Disease—Eosinophilic Pneumonia
Definition
A group of etiologically and clinically heterogeneous disorders with tissue eosinophilia and usually but not invariably blood eosinophilia—Loeffler infiltrate Acute eosinophilic pneumonia Chronic eosinophilic pneumonia Idiopathic hypereosinophilic syndrome.
Epidemiology
Chronic eosinophilic pneumonia is often associated with atopic disorders (especially asthma) Women are affected twice as often as men Peak occurrence at age 30–40 years Hypereosinophilia syndrome is more common in men than women by a ratio of 7: 1.
Etiology, pathophysiology, pathogenesis
Etiology is either unclear or reactive secondary to drugs, parasites (ascarids, amebas), fungi, etc. Morphologic findings include edema, and alveolar and interstitial eosinophilic infiltrates.
Imaging Signs
Modality of choice
CT is usually preferable to plain radiography.
Radiographic and CT findings
– Loeffler syndrome: Ill-defined transient or migrating nonsegmental infiltrates CT shows ground-glass or denser foci with halos.
– Acute eosinophilic pneumonia: Bilateral reticular and nodular nonsegmental opacities CT shows ground-glass opacities.
– Chronic eosinophilic pneumonia: Homogeneous peripheral subpleural shadows (“negative image” of the edema) persisting for months, bilateral in 50% of cases, nonsegmental, predilection for the upper lobe, air bronchogram may be present Resolves leaving bandlike densities parallel to the pleura CT allows better evaluation of the characteristic topology.
– Idiopathic hypereosinophilic syndrome: Loeffler-like picturebut persistent, due at least partially to cardiac involvement Pleural effusion occurs in 50% of cases.
Pathognomonic findings
– Acute eosinophilic pneumonia: Edemalike infiltrates.
– Chronic eosinophilic pneumonia: Peripheral subpleural shadows (“negative image” of the edema) which resolve leaving bandlike densities parallel to the pleura.
– Loeffler syndrome: Transient infiltrates with halo.
– Idiopathic hypereosinophilic syndrome: Nodular infiltrates with halo.
Clinical Aspects
Typical presentation
– Loeffler syndrome: Minimally symptomatic.
– Acute eosinophilic pneumonia: Fever Dyspnea Myalgia Malaise Blood eosinophilia is not invariably present.
– Chronic eosinophilic pneumonia: Fever Dyspnea Cough Asthma is present in 50% of cases.
– Idiopathic hypereosinophilic syndrome: Long history Severe eosinophilia Involves multiple organ systems (heart more than lung).
Therapeutic options
Simple pulmonary eosinophilia usually resolves spontaneously Corticosteroids are indicated in the other idiopathic eosinophilic disorders.
Course and prognosis
Simple pulmonary eosinophilia has a good prognosis even without treatment Acute and chronic eosinophilic pneumonia and hypereosinophilic syndrome have a good prognosis with steroid therapy Recurrence is rare in acute eosinophilic pneumonia but common in chronic eosinophilic pneumonia.
What does the clinician want to know?